Literature DB >> 6179862

HLA-linked and unlinked determinants of multiple sclerosis.

H Z Ho, J L Tiwari, R W Haile, P I Terasaki, N E Morton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6179862     DOI： 10.1007/BF00345910

Source DB:  PubMed          Journal:  Immunogenetics        ISSN： 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  25 in total

1.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

Authors:  G A SCHUMACHER; G BEEBE; R F KIBLER; L T KURLAND; J F KURTZKE; F MCDOWELL; B NAGLER; W A SIBLEY; W W TOURTELLOTTE; T L WILLMON
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

2.  HLA-DW2, viral immunity and family studies in multiple sclerosis.

Authors:  G J Stewart; A Basten; J Guinan; H V Bashir; J Cameron; J G McLeod
Journal:  J Neurol Sci       Date:  1977-06       Impact factor: 3.181

3.  Histocompatibility determinants in multiple sclerosis, with special reference to clinical course.

Authors:  C Jersild; T Fog; G S Hansen; M Thomsen; A Svejgaard; B Dupont
Journal:  Lancet       Date:  1973-12-01       Impact factor: 79.321

4.  Genetic susceptibility to multiple sclerosis.

Authors:  B R Visscher; R Detels; J Dudley; R W Haile; R M Malmgren; P I Terasaki; M S Park
Journal:  Neurology       Date:  1979-10       Impact factor: 9.910

5.  HL-A determinants and familial multiple sclerosis: HL-A typing of 13 families with at least two affected members.

Authors:  L Hens; H Carton
Journal:  Tissue Antigens       Date:  1978-01

6.  Resolution of linkage for irregular phenotype systems.

Authors:  N E Morton; J M Lalouel
Journal:  Hum Hered       Date:  1981       Impact factor: 0.444

7.  HLA antigen segregation analysis in multiple sclerosis (MS) families.

Authors:  J Bertrams; E Kuwert
Journal:  Z Immunitatsforsch Immunobiol       Date:  1976-11

8.  Multiple sclerosis in the Orkney and Shetland Islands. III: Histocompatibility determinants.

Authors:  D C Poskanzer; P I Terasaki; L B Prenney; J L Sheridan; M S Park
Journal:  J Epidemiol Community Health       Date:  1980-12       Impact factor: 3.710

9.  Segregation and linkage analysis of 40 multiplex multiple sclerosis families.

Authors:  R W Haile; L Iselius; S E Hodge; N E Morton; R Detels
Journal:  Hum Hered       Date:  1981       Impact factor: 0.444

10.  Inclusion group systems and cis-trans effects in responses controlled by the two complementing Ir-GLphi genes.

Authors:  M E Dorf; P H Maurer; F Merryman; B Benacerraf
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307
View more
  11 in total

1.  Inheritance mode of multiple sclerosis: the effect of HLA class II alleles is stronger than additive.

Authors:  Maartje Boon; Ilja M Nolte; Jacques De Keyser; Charles H C M Buys; Gerard J te Meerman
Journal:  Hum Genet       Date:  2004-09       Impact factor: 4.132

2.  Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities.

Authors:  O Olerup; J Hillert; S Fredrikson; T Olsson; S Kam-Hansen; E Möller; B Carlsson; J Wallin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

3.  Assessing the role of HLA-linked and unlinked determinants of disease.

Authors:  N Risch
Journal:  Am J Hum Genet       Date:  1987-01       Impact factor: 11.025

4.  HLA and multiple sclerosis in south east Wales.

Authors:  R J Swingler; P F Kirk; C Darke; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-09       Impact factor: 10.154

5.  Spinal fluid lymphocytes responsive to autologous and allogeneic cells in multiple sclerosis and control individuals.

Authors:  G Birnbaum; L Kotilinek; M Schwartz; M Sternad
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

6.  Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis.

Authors:  B L Kotzin; S Karuturi; Y K Chou; J Lafferty; J M Forrester; M Better; G E Nedwin; H Offner; A A Vandenbark
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

7.  Genetic susceptibility to multiple sclerosis in the Shanghai Chinese is not linked to the myelin basic protein gene microsatellite.

Authors:  M A Kelly; Y Zhang; C H Mijovic; K Y Chou; A H Barnett; D A Francis
Journal:  Clin Mol Pathol       Date:  1995-04

Review 8.  TCR peptide therapy in human autoimmune diseases.

Authors:  A A Vandenbark; E Morgan; R Bartholomew; D Bourdette; R Whitham; D Carlo; D Gold; G Hashim; H Offner
Journal:  Neurochem Res       Date:  2001-06       Impact factor: 3.996

Review 9.  Autologous T-cell vaccination for multiple sclerosis: a perspective on progress.

Authors:  Arthur A Vandenbark; Rivka Abulafia-Lapid
Journal:  BioDrugs       Date:  2008       Impact factor: 5.807

10.  Combined influences of Gm and HLA phenotypes upon multiple sclerosis susceptibility and severity.

Authors:  J P Salier; R Sesboüé; C Martin-Mondière; M Daveau; P Cesaro; B Cavelier; A Coquerel; L Legrand; J M Goust; J D Degos
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.